What percent of CUE is sold short?

60.3% of Cue Biopharma (CUE) trading volume was short last week. Track days-to-cover and borrow rate against insider and hedge fund flow.

Is CUE a short squeeze candidate?

Compare short volume, days-to-cover, and borrow rate to insider buying — when insiders accumulate against heavy short interest, the squeeze setup gets stronger.

How is short volume different from short interest?

Short volume is daily shorting activity reported by FINRA; short interest is the bi-monthly snapshot of outstanding short positions. We track both for Cue Biopharma (CUE).

CUE Short Volume Hit 60.3%

$25.57

+0.32 (+1.27%)

Weekly Expected Move ±18.5%

$16 $21 $26 $30 $35

NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 38 · $185.8M mcap · 7M float · 3.10% daily turnover · Short 60% of daily vol

Short Volume Summary

2026-10-01

70.1%

Short Ratio

of total volume

53.2%

20-Day Avg

49.8%

50-Day Avg

▲ Rising

5-Day Trend

0.1M

Short Volume

0.1M

Total Volume

Daily Short Volume Ratio

Short Volume vs Total Volume

Exchange Breakdown

2026-10-01

Exchange	Short Volume	Total Volume	Short %
NASDAQ	57,042	80,069	71.2%
NYSE	2,586	4,813	53.7%
BATS	1,441	2,217	65.0%

CUE Short Interest

Short Volume Summary

Daily Short Volume Ratio

Short Volume vs Total Volume

Exchange Breakdown

Sign in to InsiderStreet